0

527005

SHREEPAC

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SHREE PACETRONIX LTD. Share Price Today

Investment Returns

Over 1 Month -1.09% Over 3 Months 14.84% Over 6 Months -43.71% Over 1 Year 56.39%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SHREE PACETRONIX LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 47.30
  • P/E Ratio (TTM) 16.21
  • Beta 1.13
  • Book Value / share 47.49
  • Return on equity 5.54%
  • EPS (TTM) 8.05
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.97
info icon alternate text

SHREE PACETRONIX LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 5.37
Operating Expense 4.14
Net Profit 0.97
Net Profit Margin (%) 18.06
Earnings Per Share (EPS) 2.67
EBITDA 1.53
Effective Tax Rate (%) 23.62
Particulars DEC 2025 (Values in Cr)
Revenue 4.33
Operating Expense 4.18
Net Profit 0.06
Net Profit Margin (%) 1.38
Earnings Per Share (EPS) 0.17
EBITDA 0.46
Effective Tax Rate (%) 62.50
Particulars SEP 2025 (Values in Cr)
Revenue 6.59
Operating Expense 4.86
Net Profit 1.32
Net Profit Margin (%) 20.03
Earnings Per Share (EPS) 3.68
EBITDA 2.05
Effective Tax Rate (%) 25.00
Particulars JUN 2025 (Values in Cr)
Revenue 5.34
Operating Expense 4.47
Net Profit 0.67
Net Profit Margin (%) 12.54
Earnings Per Share (EPS) 1.86
EBITDA 1.18
Effective Tax Rate (%) 25.55
Particulars MAR 2025 (Values in Cr)
Revenue 4.28
Operating Expense 3.65
Net Profit 0.47
Net Profit Margin (%) 10.98
Earnings Per Share (EPS) 1.29
EBITDA 0.98
Effective Tax Rate (%) 29.23
Particulars MAR 2026 (Values in Cr)
Revenue 21.64
Operating Expense 17.66
Net Profit 3.02
Net Profit Margin (%) 13.95
Earnings Per Share (EPS) 8.31
EBITDA 5.20
Effective Tax Rate (%) 26.16
Particulars MAR 2025 (Values in Cr)
Revenue 16.80
Operating Expense 15.88
Net Profit 0.75
Net Profit Margin (%) 4.46
Earnings Per Share (EPS) 2.09
EBITDA 2.32
Effective Tax Rate (%) 27.88
Particulars MAR 2024 (Values in Cr)
Revenue 22.04
Operating Expense 17.55
Net Profit 3.36
Net Profit Margin (%) 15.24
Earnings Per Share (EPS) 9.33
EBITDA 5.80
Effective Tax Rate (%) 27.27
Particulars MAR 2023 (Values in Cr)
Revenue 20.19
Operating Expense 15.69
Net Profit 3.25
Net Profit Margin (%) 16.09
Earnings Per Share (EPS) 9.02
EBITDA 5.52
Effective Tax Rate (%) 29.34
Particulars MAR 2022 (Values in Cr)
Revenue 9.03
Operating Expense 8.20
Net Profit 0.65
Net Profit Margin (%) 7.19
Earnings Per Share (EPS) 1.81
EBITDA 1.66
Effective Tax Rate (%) 26.13
Particulars MAR 2025 (Values in Cr)
Book Value / Share 38.29
ROE % 5.59
ROCE % 9.10
Total Debt to Total Equity 0.35
EBITDA Margin 14.64
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.21
ROE % 29.60
ROCE % 34.65
Total Debt to Total Equity 0.29
EBITDA Margin 27.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 26.88
ROE % 40.55
ROCE % 46.02
Total Debt to Total Equity 0.33
EBITDA Margin 27.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 17.82
ROE % 12.96
ROCE % 14.71
Total Debt to Total Equity 0.52
EBITDA Margin 20.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 15.65
ROE % 0.89
ROCE % 5.40
Total Debt to Total Equity 0.58
EBITDA Margin 13.10
Particulars MAR 2025 (Values in Cr)
Book Value / Share 38.64
ROE % 5.54
ROCE % 9.01
Total Debt to Total Equity 0.34
EBITDA Margin 13.93
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.55
ROE % 29.27
ROCE % 34.41
Total Debt to Total Equity 0.28
EBITDA Margin 26.72
Particulars MAR 2023 (Values in Cr)
Book Value / Share 27.22
ROE % 39.76
ROCE % 45.67
Total Debt to Total Equity 0.31
EBITDA Margin 27.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 18.19
ROE % 10.44
ROCE % 12.80
Total Debt to Total Equity 0.45
EBITDA Margin 18.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 16.38
ROE % 3.10
ROCE % 7.62
Total Debt to Total Equity 0.46
EBITDA Margin 15.34
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.11
Total Assets 23.04
Total Liabilities 23.04
Total Equity 13.78
Share Outstanding 0
Price to Book Ratio 1.61
Return on Assets (%) 3.25
Return on Capital (%) 3.98
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.80
Total Assets 21.74
Total Liabilities 21.74
Total Equity 13.03
Share Outstanding 0
Price to Book Ratio 4.15
Return on Assets (%) 15.44
Return on Capital (%) 19.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.84
Total Assets 16.54
Total Liabilities 16.54
Total Equity 9.67
Share Outstanding 0
Price to Book Ratio 3.59
Return on Assets (%) 19.70
Return on Capital (%) 27.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.43
Total Assets 12.17
Total Liabilities 12.17
Total Equity 6.41
Share Outstanding 0
Price to Book Ratio 1.12
Return on Assets (%) 6.41
Return on Capital (%) 8.26
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 10.97
Total Liabilities 10.97
Total Equity 5.63
Share Outstanding 0
Price to Book Ratio 0.71
Return on Assets (%) 0.48
Return on Capital (%) 0.6
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.10
Total Assets 23.03
Total Liabilities 23.03
Total Equity 13.90
Share Outstanding 0
Price to Book Ratio 1.61
Return on Assets (%) 3.26
Return on Capital (%) 3.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 21.81
Total Liabilities 21.81
Total Equity 13.15
Share Outstanding 0
Price to Book Ratio 4.15
Return on Assets (%) 15.39
Return on Capital (%) 19.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.83
Total Assets 16.60
Total Liabilities 16.60
Total Equity 9.79
Share Outstanding 0
Price to Book Ratio 3.59
Return on Assets (%) 19.55
Return on Capital (%) 27.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.57
Total Assets 12.04
Total Liabilities 12.04
Total Equity 6.54
Share Outstanding 0
Price to Book Ratio 1.12
Return on Assets (%) 5.41
Return on Capital (%) 6.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.69
Total Assets 10.69
Total Liabilities 10.69
Total Equity 5.89
Share Outstanding 0
Price to Book Ratio 0.71
Return on Assets (%) 1.71
Return on Capital (%) 2.13
Particulars MAR 2025 (Values in Cr)
Net Income 1.04
Cash from Operations 1.09
Cash from Investing -0.04
Cash from Financing 0.18
Net change in Cash 0.14
Free Cash Flow 1.80
Particulars MAR 2024 (Values in Cr)
Net Income 4.62
Cash from Operations 1.11
Cash from Investing -1.66
Cash from Financing 1.74
Net change in Cash 0.04
Free Cash Flow 2.49
Particulars MAR 2023 (Values in Cr)
Net Income 4.62
Cash from Operations 2.63
Cash from Investing -1.41
Cash from Financing -1.10
Net change in Cash -0.82
Free Cash Flow 3.87
Particulars MAR 2022 (Values in Cr)
Net Income 1.06
Cash from Operations 1.89
Cash from Investing -1.18
Cash from Financing -0.44
Net change in Cash 0.12
Free Cash Flow 2.29
Particulars MAR 2021 (Values in Cr)
Net Income 0.13
Cash from Operations 1.26
Cash from Investing -0.53
Cash from Financing -0.31
Net change in Cash 0.24
Free Cash Flow 2.02
Particulars MAR 2025 (Values in Cr)
Net Income 1.04
Cash from Operations 1.15
Cash from Investing -0.03
Cash from Financing 0.11
Net change in Cash 0.13
Free Cash Flow 1.86
Particulars MAR 2024 (Values in Cr)
Net Income 4.62
Cash from Operations 1.11
Cash from Investing -1.67
Cash from Financing 1.74
Net change in Cash 0.04
Free Cash Flow 2.49
Particulars MAR 2023 (Values in Cr)
Net Income 4.59
Cash from Operations 3.31
Cash from Investing -1.40
Cash from Financing -0.96
Net change in Cash 0.02
Free Cash Flow 4.53
Particulars MAR 2022 (Values in Cr)
Net Income 0.88
Cash from Operations 0.72
Cash from Investing -1.10
Cash from Financing -0.14
Net change in Cash -0.65
Free Cash Flow 1.12
Particulars MAR 2021 (Values in Cr)
Net Income 0.31
Cash from Operations 1.16
Cash from Investing -0.58
Cash from Financing -0.15
Net change in Cash 0.25
Free Cash Flow 1.83
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8099.40 59.53 12.29 116456.95 6680.00 8490.30
FORTIS MALAR HOSPITALS LIMITED 53.36 24.14 2.91 100.01 40.75 77.00
TRANSGENE BIOTEK LTD. 3.10 0.00 2.80 23.49 1.83 5.26
VIMTA LABS LTD. 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8099.40 77.57 11.68 116456.95 6680.00 8490.30
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.30 0.00 -9.56 29.36 30.30 57.48
KOVAI MEDICAL CENTER & HOSPITA 5372.55 24.04 4.45 5877.57 5010.00 6725.00

SHREE PACETRONIX LTD. shareholding pattern

Holding
68.3%
31.69%
10.85%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

SHREE PACETRONIX LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
126.05 -3.40 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 135.60
  • 26 Days 135.10
  • 10 Days 136.20
  • 50 Days 135.00
  • 12 Days 136.20
  • 100 Days 143.20
  • 20 Days 135.60
  • 200 Days 150.90
133.50 PIVOT
First Support 122.30 First Resistance 141.95 Second Support 113.85 Second Resistance 153.15 Third Support 102.65 Third Resistance 161.60
RSI 46.09 ADX 19.26 MACD 1.77 Williams % R -58.15 Commodity Channel Index (CCI) -44.41
Date 2026-06-01 Week 3041.00 Same Day 1305.00 Month 2063.00
1 Year 1.14 3 Year 0.62
Over 1 Month
-1.09% down
Over 1 Year
56.39% down
Over 3 Months
14.84% down
Over 3 Years
-2.73% down
Over 6 Months
-43.71% down
Over 5 Years
70.06% down

SHREE PACETRONIX LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
24 Sep 2007 0.5 Final 26 Sep 2007 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Shree Pacetronix Ltd?

Answer Field

Shree Pacetronix Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 126.05 as on Jun 03 2026 03:29 PM.

What is the Market Cap of Shree Pacetronix Ltd Share?

Answer Field

The market cap of Shree Pacetronix Ltd for NSE ₹ 0.00 & for BSE ₹ 47.30 as on Jun 03 2026 03:29 PM.

What is the 52 Week High and Low of Shree Pacetronix Ltd?

Answer Field

The 52 Week High and Low of Shree Pacetronix Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 283.15 and ₹ 66.10.

What is 1 year return for Shree Pacetronix Ltd?

Answer Field

The 1 year returns on the stock has been 56.10%.

What is the P/E Ratio of Shree Pacetronix Ltd Share?

Answer Field

As on Jun 03 2026 03:29 PM the price-to-earnings (PE) ratio for Shree Pacetronix Ltd share is 16.21.

What is the PB ratio of Shree Pacetronix Ltd Share?

Answer Field

As on Jun 03 2026 03:29 PM, the price-to-book (PB) ratio for Shree Pacetronix Ltd share is 47.49.

How to Buy Shree Pacetronix Ltd Share?

Answer Field

You can trade in Shree Pacetronix Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shree Pacetronix Ltd Share on Bajaj Broking App?

Answer Field

To buy Shree Pacetronix Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shree Pacetronix Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|